ClinicalTrials.Veeva

Menu

Evaluation of the Fortilink IBF System With TETRAfuse Technology (ENTRUST)

R

RTI Surgical

Status

Completed

Conditions

Cervical and Lumbar Fusion

Treatments

Device: Fortilink IBF System with TETRAfuse Technology

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.

Full description

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.

The study will include up to 110 patients at up to 8 US sites. All patients implanted with the Fortilink System at a site will be included in the data collection. The goal is to collect data for at least 100 subjects, but the sample size will be capped at 110 to ensure that all patients at a given site are included in the analysis.

Enrollment

119 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient must have had an attempted implant of the Fortilink IBF System

Exclusion criteria

  • There are no exclusion criteria

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems